

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.54501760 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.49044886 |
| 3 | negative regulation of cell killing (GO:0031342) | 6.49044886 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.27300550 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.27300550 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 6.27300550 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 6.27300550 |
| 8 | modulation by symbiont of host defense response (GO:0052031) | 6.27300550 |
| 9 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.27300550 |
| 10 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.85240411 |
| 11 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.82459884 |
| 12 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.56183864 |
| 13 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.21898408 |
| 14 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.20750473 |
| 15 | macrophage activation involved in immune response (GO:0002281) | 5.03047774 |
| 16 | detection of molecule of bacterial origin (GO:0032490) | 5.00729901 |
| 17 | detection of other organism (GO:0098543) | 4.98733529 |
| 18 | neutrophil activation involved in immune response (GO:0002283) | 4.95494870 |
| 19 | response to interleukin-15 (GO:0070672) | 4.69512447 |
| 20 | detection of bacterium (GO:0016045) | 4.67620223 |
| 21 | detection of external biotic stimulus (GO:0098581) | 4.63489590 |
| 22 | response to peptidoglycan (GO:0032494) | 4.57425769 |
| 23 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.54498810 |
| 24 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.50871904 |
| 25 | microglial cell activation (GO:0001774) | 4.48967437 |
| 26 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.48946136 |
| 27 | cellular response to interleukin-15 (GO:0071350) | 4.40399058 |
| 28 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.39604692 |
| 29 | response to host immune response (GO:0052572) | 4.34311106 |
| 30 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.34311106 |
| 31 | cellular extravasation (GO:0045123) | 4.31545338 |
| 32 | regulation of gamma-delta T cell activation (GO:0046643) | 4.25933860 |
| 33 | neutrophil activation (GO:0042119) | 4.19061245 |
| 34 | negative regulation of interleukin-12 production (GO:0032695) | 4.18237461 |
| 35 | respiratory burst (GO:0045730) | 4.10264899 |
| 36 | leukocyte aggregation (GO:0070486) | 4.05575318 |
| 37 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 4.01778513 |
| 38 | detection of biotic stimulus (GO:0009595) | 4.00891136 |
| 39 | response to host (GO:0075136) | 3.96995656 |
| 40 | response to host defenses (GO:0052200) | 3.96995656 |
| 41 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.96995656 |
| 42 | neutrophil mediated immunity (GO:0002446) | 3.94918040 |
| 43 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.91191446 |
| 44 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.89989158 |
| 45 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.87055872 |
| 46 | macrophage activation (GO:0042116) | 3.86997407 |
| 47 | immunoglobulin mediated immune response (GO:0016064) | 3.78267105 |
| 48 | negative regulation of T cell mediated immunity (GO:0002710) | 3.74715375 |
| 49 | myeloid cell activation involved in immune response (GO:0002275) | 3.73996692 |
| 50 | granulocyte activation (GO:0036230) | 3.71660743 |
| 51 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.71003017 |
| 52 | B cell receptor signaling pathway (GO:0050853) | 3.68242937 |
| 53 | regulation of mast cell degranulation (GO:0043304) | 3.68073241 |
| 54 | response to type I interferon (GO:0034340) | 3.62545235 |
| 55 | cellular response to type I interferon (GO:0071357) | 3.61412445 |
| 56 | type I interferon signaling pathway (GO:0060337) | 3.61412445 |
| 57 | myeloid leukocyte mediated immunity (GO:0002444) | 3.48816505 |
| 58 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.46619992 |
| 59 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.44895316 |
| 60 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.43840210 |
| 61 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.43840210 |
| 62 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.43126674 |
| 63 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.42774073 |
| 64 | negative regulation of phagocytosis (GO:0050765) | 3.37120807 |
| 65 | regulation of B cell differentiation (GO:0045577) | 3.32579416 |
| 66 | leukocyte degranulation (GO:0043299) | 3.32578241 |
| 67 | positive regulation of mast cell activation (GO:0033005) | 3.31210526 |
| 68 | negative thymic T cell selection (GO:0045060) | 3.25209080 |
| 69 | regulation of mast cell activation (GO:0033003) | 3.23986636 |
| 70 | regulation of tolerance induction (GO:0002643) | 3.23035203 |
| 71 | regulation of T cell tolerance induction (GO:0002664) | 3.22784610 |
| 72 | germinal center formation (GO:0002467) | 3.21765257 |
| 73 | negative T cell selection (GO:0043383) | 3.21387381 |
| 74 | regulation of leukocyte degranulation (GO:0043300) | 3.19299818 |
| 75 | defense response to protozoan (GO:0042832) | 3.18063423 |
| 76 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.17847103 |
| 77 | positive regulation of B cell differentiation (GO:0045579) | 3.15110032 |
| 78 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.14582976 |
| 79 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.13764054 |
| 80 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.13059108 |
| 81 | dendritic cell migration (GO:0036336) | 3.11300284 |
| 82 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.10594700 |
| 83 | positive regulation of interferon-alpha production (GO:0032727) | 3.10078935 |
| 84 | dendritic cell chemotaxis (GO:0002407) | 3.08545148 |
| 85 | positive regulation of granulocyte differentiation (GO:0030854) | 3.06143966 |
| 86 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.05305149 |
| 87 | negative regulation of type 2 immune response (GO:0002829) | 3.04985693 |
| 88 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.04297606 |
| 89 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.03513248 |
| 90 | B cell mediated immunity (GO:0019724) | 3.02986222 |
| 91 | response to muramyl dipeptide (GO:0032495) | 3.01885608 |
| 92 | response to interferon-alpha (GO:0035455) | 3.00782719 |
| 93 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.99913783 |
| 94 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.98892705 |
| 95 | positive thymic T cell selection (GO:0045059) | 2.96933382 |
| 96 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.90680003 |
| 97 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.88432083 |
| 98 | activated T cell proliferation (GO:0050798) | 2.88101643 |
| 99 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.86257418 |
| 100 | regulation of interferon-alpha production (GO:0032647) | 2.86066901 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.95774832 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.90647370 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.12698938 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.01323743 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.79515740 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.67262351 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.21258296 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.08058340 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.00468965 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.92597247 |
| 11 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.85107601 |
| 12 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.84592642 |
| 13 | SPI1_23127762_ChIP-Seq_K562_Human | 2.77012467 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.69079770 |
| 15 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.68690896 |
| 16 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.64878368 |
| 17 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.61914495 |
| 18 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.58003376 |
| 19 | MYB_26560356_Chip-Seq_TH2_Human | 2.57136619 |
| 20 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.54553156 |
| 21 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.52716587 |
| 22 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.47971224 |
| 23 | MAF_26560356_Chip-Seq_TH1_Human | 2.45738264 |
| 24 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.30296973 |
| 25 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.28149687 |
| 26 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.23255285 |
| 27 | * MYB_26560356_Chip-Seq_TH1_Human | 2.20015547 |
| 28 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.19313050 |
| 29 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.16954097 |
| 30 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.14846890 |
| 31 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.14141556 |
| 32 | MYC_22102868_ChIP-Seq_BL_Human | 2.05660581 |
| 33 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.99937492 |
| 34 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.94848377 |
| 35 | MAF_26560356_Chip-Seq_TH2_Human | 1.90741085 |
| 36 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86246657 |
| 37 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.84818793 |
| 38 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.79377276 |
| 39 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.75722270 |
| 40 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.73482514 |
| 41 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.70541295 |
| 42 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.67643123 |
| 43 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.67223864 |
| 44 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.67060065 |
| 45 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.64820459 |
| 46 | GATA1_22025678_ChIP-Seq_K562_Human | 1.62288652 |
| 47 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60698950 |
| 48 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.56368248 |
| 49 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.52896151 |
| 50 | GATA3_26560356_Chip-Seq_TH2_Human | 1.50960827 |
| 51 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.50606538 |
| 52 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.45592707 |
| 53 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.44752921 |
| 54 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44407786 |
| 55 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.43487120 |
| 56 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.43384799 |
| 57 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.42803292 |
| 58 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.42336519 |
| 59 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.41348435 |
| 60 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.39491402 |
| 61 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.37398852 |
| 62 | GATA1_19941826_ChIP-Seq_K562_Human | 1.37078110 |
| 63 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.28790887 |
| 64 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.28272215 |
| 65 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.27168582 |
| 66 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23982385 |
| 67 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.23467815 |
| 68 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22882991 |
| 69 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19711436 |
| 70 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18863898 |
| 71 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.17975821 |
| 72 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17846462 |
| 73 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17824430 |
| 74 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.15914940 |
| 75 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.15319262 |
| 76 | GATA2_19941826_ChIP-Seq_K562_Human | 1.13471695 |
| 77 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.11398782 |
| 78 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.11302718 |
| 79 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10661709 |
| 80 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07965238 |
| 81 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.07941763 |
| 82 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.07559278 |
| 83 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07557731 |
| 84 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07182284 |
| 85 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.05646323 |
| 86 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.03179789 |
| 87 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.02480344 |
| 88 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98855469 |
| 89 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.97348164 |
| 90 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.96836618 |
| 91 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.91833787 |
| 92 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.89718519 |
| 93 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.89136071 |
| 94 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.88845429 |
| 95 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.84842160 |
| 96 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.83146033 |
| 97 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.80488654 |
| 98 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.80470632 |
| 99 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.78552558 |
| 100 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.73260660 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 5.43786058 |
| 2 | MP0003436_decreased_susceptibility_to | 4.11122484 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.76815298 |
| 4 | MP0003303_peritoneal_inflammation | 3.49618675 |
| 5 | MP0002419_abnormal_innate_immunity | 3.12475757 |
| 6 | MP0001800_abnormal_humoral_immune | 2.98427380 |
| 7 | MP0005025_abnormal_response_to | 2.87024875 |
| 8 | MP0009785_altered_susceptibility_to | 2.77399651 |
| 9 | MP0005671_abnormal_response_to | 2.77187561 |
| 10 | MP0000685_abnormal_immune_system | 2.75711553 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.74278473 |
| 12 | MP0001790_abnormal_immune_system | 2.70186198 |
| 13 | MP0005387_immune_system_phenotype | 2.70186198 |
| 14 | MP0002132_abnormal_respiratory_system | 2.62535895 |
| 15 | MP0002420_abnormal_adaptive_immunity | 2.61154712 |
| 16 | MP0002723_abnormal_immune_serum | 2.61050251 |
| 17 | MP0001819_abnormal_immune_cell | 2.57907614 |
| 18 | MP0003763_abnormal_thymus_physiology | 2.57179870 |
| 19 | MP0002452_abnormal_antigen_presenting | 2.48742295 |
| 20 | MP0003300_gastrointestinal_ulcer | 2.25968515 |
| 21 | MP0004381_abnormal_hair_follicle | 2.22646101 |
| 22 | MP0008260_abnormal_autophagy | 2.21090041 |
| 23 | MP0002148_abnormal_hypersensitivity_rea | 2.17732256 |
| 24 | MP0005464_abnormal_platelet_physiology | 2.16727854 |
| 25 | MP0006082_CNS_inflammation | 2.15821104 |
| 26 | MP0003191_abnormal_cellular_cholesterol | 2.13285976 |
| 27 | MP0002398_abnormal_bone_marrow | 2.08963413 |
| 28 | MP0002405_respiratory_system_inflammati | 2.08659719 |
| 29 | MP0001533_abnormal_skeleton_physiology | 2.01813611 |
| 30 | MP0000716_abnormal_immune_system | 1.98054407 |
| 31 | MP0002396_abnormal_hematopoietic_system | 1.88444731 |
| 32 | MP0009278_abnormal_bone_marrow | 1.81714558 |
| 33 | MP0000465_gastrointestinal_hemorrhage | 1.81377677 |
| 34 | MP0002722_abnormal_immune_system | 1.75072386 |
| 35 | MP0010155_abnormal_intestine_physiology | 1.73028202 |
| 36 | MP0001845_abnormal_inflammatory_respons | 1.70265687 |
| 37 | MP0003828_pulmonary_edema | 1.69841316 |
| 38 | MP0000689_abnormal_spleen_morphology | 1.68835909 |
| 39 | MP0005451_abnormal_body_composition | 1.68724742 |
| 40 | MP0002277_abnormal_respiratory_mucosa | 1.67872660 |
| 41 | MP0000703_abnormal_thymus_morphology | 1.67455600 |
| 42 | MP0003866_abnormal_defecation | 1.65090077 |
| 43 | MP0004883_abnormal_blood_vessel | 1.59638857 |
| 44 | MP0002429_abnormal_blood_cell | 1.58080350 |
| 45 | MP0003172_abnormal_lysosome_physiology | 1.55102402 |
| 46 | MP0005397_hematopoietic_system_phenotyp | 1.54631023 |
| 47 | MP0001545_abnormal_hematopoietic_system | 1.54631023 |
| 48 | MP0004947_skin_inflammation | 1.48877131 |
| 49 | MP0009764_decreased_sensitivity_to | 1.47558111 |
| 50 | MP0003183_abnormal_peptide_metabolism | 1.47403006 |
| 51 | MP0008469_abnormal_protein_level | 1.39344437 |
| 52 | MP0009333_abnormal_splenocyte_physiolog | 1.32995836 |
| 53 | MP0005075_abnormal_melanosome_morpholog | 1.31732499 |
| 54 | MP0000858_altered_metastatic_potential | 1.29628284 |
| 55 | MP0002166_altered_tumor_susceptibility | 1.27572979 |
| 56 | MP0001851_eye_inflammation | 1.23352687 |
| 57 | MP0005164_abnormal_response_to | 1.21897193 |
| 58 | MP0005310_abnormal_salivary_gland | 1.17058359 |
| 59 | MP0003656_abnormal_erythrocyte_physiolo | 1.13008778 |
| 60 | MP0002998_abnormal_bone_remodeling | 1.09626566 |
| 61 | MP0000015_abnormal_ear_pigmentation | 1.07924608 |
| 62 | MP0003075_altered_response_to | 1.04951546 |
| 63 | MP0008004_abnormal_stomach_pH | 1.02466424 |
| 64 | MP0005166_decreased_susceptibility_to | 0.97421273 |
| 65 | MP0003806_abnormal_nucleotide_metabolis | 0.97194006 |
| 66 | MP0000569_abnormal_digit_pigmentation | 0.93235689 |
| 67 | MP0004510_myositis | 0.90997504 |
| 68 | MP0003690_abnormal_glial_cell | 0.90154364 |
| 69 | MP0004808_abnormal_hematopoietic_stem | 0.89208356 |
| 70 | MP0009763_increased_sensitivity_to | 0.81488232 |
| 71 | MP0002138_abnormal_hepatobiliary_system | 0.76277360 |
| 72 | MP0004484_altered_response_of | 0.75839619 |
| 73 | MP0001663_abnormal_digestive_system | 0.75674675 |
| 74 | MP0001986_abnormal_taste_sensitivity | 0.75347974 |
| 75 | MP0005083_abnormal_biliary_tract | 0.75172966 |
| 76 | MP0003045_fibrosis | 0.73492185 |
| 77 | MP0002006_tumorigenesis | 0.73177136 |
| 78 | MP0005390_skeleton_phenotype | 0.71989931 |
| 79 | MP0008874_decreased_physiological_sensi | 0.70230059 |
| 80 | MP0005174_abnormal_tail_pigmentation | 0.69974277 |
| 81 | MP0000343_altered_response_to | 0.69833955 |
| 82 | MP0004130_abnormal_muscle_cell | 0.69417461 |
| 83 | MP0001873_stomach_inflammation | 0.64988144 |
| 84 | MP0001853_heart_inflammation | 0.64898777 |
| 85 | MP0009765_abnormal_xenobiotic_induced | 0.64170910 |
| 86 | MP0000490_abnormal_crypts_of | 0.63964699 |
| 87 | MP0003221_abnormal_cardiomyocyte_apopto | 0.63599889 |
| 88 | MP0003787_abnormal_imprinting | 0.61178916 |
| 89 | MP0003448_altered_tumor_morphology | 0.61164717 |
| 90 | MP0002332_abnormal_exercise_endurance | 0.60961660 |
| 91 | MP0003795_abnormal_bone_structure | 0.60761788 |
| 92 | MP0000604_amyloidosis | 0.60534646 |
| 93 | MP0000249_abnormal_blood_vessel | 0.60517568 |
| 94 | MP0005058_abnormal_lysosome_morphology | 0.58888508 |
| 95 | MP0002019_abnormal_tumor_incidence | 0.57329570 |
| 96 | MP0002933_joint_inflammation | 0.57269894 |
| 97 | MP0005376_homeostasis/metabolism_phenot | 0.57064180 |
| 98 | MP0002928_abnormal_bile_duct | 0.55702267 |
| 99 | MP0005319_abnormal_enzyme/_coenzyme | 0.54528873 |
| 100 | MP0005377_hearing/vestibular/ear_phenot | 0.49850513 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.73117545 |
| 2 | Recurrent abscess formation (HP:0002722) | 6.06036662 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 6.04988937 |
| 4 | Myositis (HP:0100614) | 6.04009232 |
| 5 | Orchitis (HP:0100796) | 5.73199966 |
| 6 | Optic neuritis (HP:0100653) | 5.45622853 |
| 7 | Retrobulbar optic neuritis (HP:0100654) | 5.45622853 |
| 8 | Hypochromic microcytic anemia (HP:0004840) | 5.08208794 |
| 9 | Stomatitis (HP:0010280) | 4.94128704 |
| 10 | Abnormality of macrophages (HP:0004311) | 4.89366848 |
| 11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.87573252 |
| 12 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.84408259 |
| 13 | Recurrent fungal infections (HP:0002841) | 4.51693749 |
| 14 | Gastrointestinal infarctions (HP:0005244) | 4.46498281 |
| 15 | Chronic obstructive pulmonary disease (HP:0006510) | 4.19105438 |
| 16 | Obstructive lung disease (HP:0006536) | 4.19105438 |
| 17 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.17583438 |
| 18 | Meningitis (HP:0001287) | 4.08648769 |
| 19 | Recurrent skin infections (HP:0001581) | 4.03036916 |
| 20 | Mediastinal lymphadenopathy (HP:0100721) | 4.00759109 |
| 21 | Keratoconjunctivitis sicca (HP:0001097) | 3.95283534 |
| 22 | Encephalitis (HP:0002383) | 3.94531547 |
| 23 | Hypochromic anemia (HP:0001931) | 3.92438756 |
| 24 | Spontaneous hematomas (HP:0007420) | 3.89555574 |
| 25 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.75429275 |
| 26 | Recurrent cutaneous fungal infections (HP:0011370) | 3.75429275 |
| 27 | Keratoconjunctivitis (HP:0001096) | 3.69363639 |
| 28 | Prolonged bleeding time (HP:0003010) | 3.62737285 |
| 29 | Gingivitis (HP:0000230) | 3.56886508 |
| 30 | T lymphocytopenia (HP:0005403) | 3.51903671 |
| 31 | Vasculitis (HP:0002633) | 3.43860971 |
| 32 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.39277723 |
| 33 | Increased IgE level (HP:0003212) | 3.39208115 |
| 34 | Urticaria (HP:0001025) | 3.37911679 |
| 35 | Abnormality of T cell number (HP:0011839) | 3.36590265 |
| 36 | Chest pain (HP:0100749) | 3.29758395 |
| 37 | Gingival bleeding (HP:0000225) | 3.18928482 |
| 38 | Panhypogammaglobulinemia (HP:0003139) | 3.18254605 |
| 39 | Cellulitis (HP:0100658) | 3.16755233 |
| 40 | Arterial thrombosis (HP:0004420) | 3.11412282 |
| 41 | Episodic fever (HP:0001954) | 3.08066029 |
| 42 | Leukocytosis (HP:0001974) | 3.05997384 |
| 43 | Granulocytopenia (HP:0001913) | 3.04103847 |
| 44 | Peritonitis (HP:0002586) | 3.03546700 |
| 45 | Microcytic anemia (HP:0001935) | 3.01145901 |
| 46 | Hemoptysis (HP:0002105) | 2.97473253 |
| 47 | Epistaxis (HP:0000421) | 2.97103688 |
| 48 | Abnormality of T cells (HP:0002843) | 2.93429392 |
| 49 | Inflammation of the large intestine (HP:0002037) | 2.92958321 |
| 50 | Recurrent viral infections (HP:0004429) | 2.85982491 |
| 51 | Gastrointestinal inflammation (HP:0004386) | 2.83118979 |
| 52 | Anorexia (HP:0002039) | 2.83003637 |
| 53 | Pulmonary embolism (HP:0002204) | 2.82651718 |
| 54 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.80548332 |
| 55 | Pulmonary infiltrates (HP:0002113) | 2.77514204 |
| 56 | Eosinophilia (HP:0001880) | 2.71990367 |
| 57 | Pustule (HP:0200039) | 2.67180590 |
| 58 | Petechiae (HP:0000967) | 2.57504773 |
| 59 | Osteomyelitis (HP:0002754) | 2.54812282 |
| 60 | Increased IgM level (HP:0003496) | 2.52999316 |
| 61 | Acute hepatic failure (HP:0006554) | 2.47605883 |
| 62 | Abnormality of T cell physiology (HP:0011840) | 2.43872877 |
| 63 | Abnormality of the pleura (HP:0002103) | 2.41633253 |
| 64 | Colitis (HP:0002583) | 2.37197928 |
| 65 | Sepsis (HP:0100806) | 2.36340782 |
| 66 | Abnormality of the peritoneum (HP:0002585) | 2.32298467 |
| 67 | Gangrene (HP:0100758) | 2.31722264 |
| 68 | Abnormality of eosinophils (HP:0001879) | 2.21406624 |
| 69 | Chronic otitis media (HP:0000389) | 2.20748453 |
| 70 | Lymphopenia (HP:0001888) | 2.19799239 |
| 71 | Slow saccadic eye movements (HP:0000514) | 2.19165170 |
| 72 | Amyloidosis (HP:0011034) | 2.15344991 |
| 73 | Toxemia of pregnancy (HP:0100603) | 2.12888742 |
| 74 | Abnormality of the endocardium (HP:0004306) | 2.10774386 |
| 75 | Polycythemia (HP:0001901) | 2.09207008 |
| 76 | Keratitis (HP:0000491) | 2.07183740 |
| 77 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.05828673 |
| 78 | Glomerulopathy (HP:0100820) | 2.05685665 |
| 79 | Skin ulcer (HP:0200042) | 2.05222864 |
| 80 | Hypergammaglobulinemia (HP:0010702) | 2.04503403 |
| 81 | Recurrent bronchitis (HP:0002837) | 2.04246033 |
| 82 | Purpura (HP:0000979) | 2.03135625 |
| 83 | Abnormal platelet volume (HP:0011876) | 2.02270687 |
| 84 | Abnormality of the pericardium (HP:0001697) | 2.02171976 |
| 85 | Viral hepatitis (HP:0006562) | 2.01519862 |
| 86 | Vertigo (HP:0002321) | 2.01093078 |
| 87 | IgM deficiency (HP:0002850) | 1.99071907 |
| 88 | Acne (HP:0001061) | 1.97125129 |
| 89 | Abnormality of iron homeostasis (HP:0011031) | 1.88141173 |
| 90 | Papilledema (HP:0001085) | 1.86965129 |
| 91 | Thrombophlebitis (HP:0004418) | 1.86648004 |
| 92 | Agammaglobulinemia (HP:0004432) | 1.86408167 |
| 93 | Autoimmune hemolytic anemia (HP:0001890) | 1.83954647 |
| 94 | Recurrent sinusitis (HP:0011108) | 1.78398743 |
| 95 | Recurrent pneumonia (HP:0006532) | 1.77647834 |
| 96 | Increased serum ferritin (HP:0003281) | 1.77010148 |
| 97 | Difficulty running (HP:0009046) | 1.77004547 |
| 98 | Skin rash (HP:0000988) | 1.75764222 |
| 99 | Subacute progressive viral hepatitis (HP:0006572) | 1.75058699 |
| 100 | Nasal polyposis (HP:0100582) | 1.73631343 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.94270459 |
| 2 | MAP4K1 | 3.54492194 |
| 3 | IRAK4 | 3.28567399 |
| 4 | BLK | 3.18611974 |
| 5 | MAP2K3 | 3.04825696 |
| 6 | GRK6 | 2.82853236 |
| 7 | ERN1 | 2.64493882 |
| 8 | FES | 2.61630814 |
| 9 | CSK | 2.57091077 |
| 10 | TYK2 | 2.56145655 |
| 11 | TNK2 | 2.39434566 |
| 12 | EPHB1 | 2.32524671 |
| 13 | ZAP70 | 2.19173823 |
| 14 | BTK | 2.08206279 |
| 15 | FGR | 1.86973683 |
| 16 | HCK | 1.86123802 |
| 17 | SYK | 1.82866688 |
| 18 | TXK | 1.82149381 |
| 19 | MARK3 | 1.74173211 |
| 20 | TAOK1 | 1.73978241 |
| 21 | JAK3 | 1.73067887 |
| 22 | MAP3K3 | 1.68639949 |
| 23 | MAP3K1 | 1.59467571 |
| 24 | IKBKE | 1.53573711 |
| 25 | JAK2 | 1.50086445 |
| 26 | PRPF4B | 1.44755370 |
| 27 | MAP3K11 | 1.43817979 |
| 28 | TAOK3 | 1.40857425 |
| 29 | LYN | 1.38469714 |
| 30 | KSR2 | 1.36834443 |
| 31 | JAK1 | 1.31440614 |
| 32 | MAP3K13 | 1.25728773 |
| 33 | MAP3K14 | 1.21753620 |
| 34 | YES1 | 1.20499960 |
| 35 | IRAK1 | 1.18787263 |
| 36 | IRAK2 | 1.18437255 |
| 37 | TBK1 | 1.14853037 |
| 38 | LCK | 1.13265832 |
| 39 | ITK | 1.07666889 |
| 40 | PTK2B | 1.06707745 |
| 41 | MARK2 | 1.05306365 |
| 42 | MAP3K2 | 1.02829361 |
| 43 | NLK | 0.98432137 |
| 44 | CSF1R | 0.98155435 |
| 45 | TEC | 0.95102199 |
| 46 | KIT | 0.90670366 |
| 47 | PTK6 | 0.88993642 |
| 48 | PDK1 | 0.88353195 |
| 49 | SIK2 | 0.86980848 |
| 50 | SIK3 | 0.86655729 |
| 51 | MATK | 0.81950555 |
| 52 | MAP3K7 | 0.81511289 |
| 53 | PRKD2 | 0.79250537 |
| 54 | FGFR3 | 0.78877260 |
| 55 | MAP3K6 | 0.78014241 |
| 56 | BMPR2 | 0.77630173 |
| 57 | PDPK1 | 0.73929843 |
| 58 | MAP3K5 | 0.73133213 |
| 59 | LRRK2 | 0.69899207 |
| 60 | STK38 | 0.69435338 |
| 61 | TRIB3 | 0.67898029 |
| 62 | PRKCQ | 0.67601912 |
| 63 | PIK3CG | 0.66236178 |
| 64 | IKBKB | 0.65527861 |
| 65 | RAF1 | 0.64043895 |
| 66 | STK10 | 0.62977529 |
| 67 | SGK3 | 0.62872311 |
| 68 | STK11 | 0.62645611 |
| 69 | TAOK2 | 0.62048349 |
| 70 | HIPK2 | 0.62035864 |
| 71 | MAP2K4 | 0.61934756 |
| 72 | PINK1 | 0.61095516 |
| 73 | SGK2 | 0.60722215 |
| 74 | MAPK12 | 0.59695121 |
| 75 | FYN | 0.59274230 |
| 76 | RET | 0.58001882 |
| 77 | TESK2 | 0.56578438 |
| 78 | PIM1 | 0.55706660 |
| 79 | DYRK1B | 0.54183125 |
| 80 | EPHA3 | 0.53635900 |
| 81 | DYRK3 | 0.50157446 |
| 82 | FGFR4 | 0.50089329 |
| 83 | TGFBR2 | 0.48487911 |
| 84 | CDK19 | 0.47062872 |
| 85 | FRK | 0.47047932 |
| 86 | MAP2K6 | 0.44122414 |
| 87 | KSR1 | 0.43070075 |
| 88 | CDC42BPA | 0.41832011 |
| 89 | STK4 | 0.39434531 |
| 90 | WNK1 | 0.38594080 |
| 91 | MAPKAPK2 | 0.38508681 |
| 92 | PRKG2 | 0.37018889 |
| 93 | SGK223 | 0.35895628 |
| 94 | SGK494 | 0.35895628 |
| 95 | SMG1 | 0.34962219 |
| 96 | CAMKK2 | 0.34761069 |
| 97 | CAMKK1 | 0.33527114 |
| 98 | CAMK4 | 0.31759913 |
| 99 | DAPK2 | 0.31614002 |
| 100 | RPS6KC1 | 0.31234182 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.97643425 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.96467771 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.67691770 |
| 4 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.50064032 |
| 5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.45132024 |
| 6 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.33984200 |
| 7 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.18965990 |
| 8 | Tuberculosis_Homo sapiens_hsa05152 | 2.18518896 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.18357256 |
| 10 | Allograft rejection_Homo sapiens_hsa05330 | 2.14932208 |
| 11 | Malaria_Homo sapiens_hsa05144 | 2.02033765 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.01901201 |
| 13 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.00893554 |
| 14 | Measles_Homo sapiens_hsa05162 | 1.92626976 |
| 15 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.91027690 |
| 16 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.88979481 |
| 17 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.81828544 |
| 18 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.80297938 |
| 19 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.75739983 |
| 20 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.70676501 |
| 21 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.68551556 |
| 22 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.61585963 |
| 23 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.54570256 |
| 24 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.49843048 |
| 25 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.46506935 |
| 26 | Influenza A_Homo sapiens_hsa05164 | 1.45713917 |
| 27 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.45665896 |
| 28 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.44038220 |
| 29 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.43697884 |
| 30 | Legionellosis_Homo sapiens_hsa05134 | 1.42311011 |
| 31 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.41389448 |
| 32 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.41027042 |
| 33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.35259656 |
| 34 | Phagosome_Homo sapiens_hsa04145 | 1.34016379 |
| 35 | Platelet activation_Homo sapiens_hsa04611 | 1.33236776 |
| 36 | Viral myocarditis_Homo sapiens_hsa05416 | 1.32577515 |
| 37 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.26619471 |
| 38 | Hepatitis B_Homo sapiens_hsa05161 | 1.22599583 |
| 39 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.20289764 |
| 40 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.17835228 |
| 41 | Hepatitis C_Homo sapiens_hsa05160 | 1.15818690 |
| 42 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.05296309 |
| 43 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.04364941 |
| 44 | Apoptosis_Homo sapiens_hsa04210 | 1.00652374 |
| 45 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.00550259 |
| 46 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.96354550 |
| 47 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.93033361 |
| 48 | Asthma_Homo sapiens_hsa05310 | 0.89589014 |
| 49 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.87346601 |
| 50 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.86431398 |
| 51 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.84958929 |
| 52 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.84847811 |
| 53 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.84478517 |
| 54 | Pertussis_Homo sapiens_hsa05133 | 0.84364428 |
| 55 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.83380641 |
| 56 | Endometrial cancer_Homo sapiens_hsa05213 | 0.81876722 |
| 57 | Shigellosis_Homo sapiens_hsa05131 | 0.81272565 |
| 58 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.80984118 |
| 59 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.80280359 |
| 60 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.79596828 |
| 61 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.79090450 |
| 62 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.75797413 |
| 63 | Endocytosis_Homo sapiens_hsa04144 | 0.75576139 |
| 64 | Salmonella infection_Homo sapiens_hsa05132 | 0.75378561 |
| 65 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.75108511 |
| 66 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.72945966 |
| 67 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.69881864 |
| 68 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.69781632 |
| 69 | Other glycan degradation_Homo sapiens_hsa00511 | 0.67879670 |
| 70 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.67335015 |
| 71 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.67032568 |
| 72 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.66363483 |
| 73 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.64357163 |
| 74 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.64307876 |
| 75 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.61467681 |
| 76 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.61435099 |
| 77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.60814867 |
| 78 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.60496018 |
| 79 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.59747176 |
| 80 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.58644894 |
| 81 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.58411237 |
| 82 | Insulin resistance_Homo sapiens_hsa04931 | 0.56690673 |
| 83 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.56634565 |
| 84 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.56021780 |
| 85 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.54996395 |
| 86 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.54590577 |
| 87 | Colorectal cancer_Homo sapiens_hsa05210 | 0.51177150 |
| 88 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.51009252 |
| 89 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.50276310 |
| 90 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.49134339 |
| 91 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.48832614 |
| 92 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.48746451 |
| 93 | HTLV-I infection_Homo sapiens_hsa05166 | 0.47973293 |
| 94 | Olfactory transduction_Homo sapiens_hsa04740 | 0.44871427 |
| 95 | Glioma_Homo sapiens_hsa05214 | 0.43509691 |
| 96 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.43411570 |
| 97 | Prostate cancer_Homo sapiens_hsa05215 | 0.43316715 |
| 98 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.42534474 |
| 99 | Long-term potentiation_Homo sapiens_hsa04720 | 0.42162773 |
| 100 | Amoebiasis_Homo sapiens_hsa05146 | 0.38431402 |

